chrisvoncsefalvay/vaers-outcomes huggingface dataset:
allergic delayed local injection site reactions; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE REACTION (allergic delayed local injection site reactions) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (allergic delayed local injection site reactions). At the time of the report, VACCINATION SITE REACTION (allergic delayed local injection site reactions) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medications reported. no treatment details reported,
pt became very drowsy around 430PM;fever rx not given p/shots because pt did not devel fever from immun;states unusual for pt to be sleepy @ that time of afternoon;pt started shaking became limp & eye rolled into head;pt restless;fever
Fever of 103.0 with ER visit on 6-29-07. Followed up with Dr Today Dr noticed rash on stomach and back. Red rash, raised. Parents denies any SOB, or anything other than fever of 100 since ER visit on 6-29-07
This spontaneous report was received from a physician via company representative refers to a 78 years old female patient who on 31-JAN-2013 was vaccinated subcutaneously (SQ) with a standard dose of live ZOSTAVAX (Lot # H020001, Exp: 02-FEB-2014) No other co-suspects were reported. No concomitant medications were reported. The patient developed a red rash, bigger than a 1x1 gauze pad in size (approximately in the 2013). The patient received treatment: covered with gauze.   The outcome of the event was unknown. The patient did not seek Medical Attention. The relatedness for the event was unknown for live ZOSTAVAX. Additional information has been requested.
Pt became pale after receiving his vaccination and passed out and had seizure like activity and became diaperetic
Rash for 8 days that started on his face and then to upper body and legs with minimal itching. 4 days before the rash; patient started on AMOXIL and given MMR. Patient had slight fever with sniffles after vaccine and possible otitis media. AMOXIL discontinued and azithromycin started.
Patient called stating she is having pain, fever on left arm. Dr. agreed to see her in clinic on that day. She had impressive cellulitis and she also had leukocytosis. Dr. changed antibiotic to doxy and cephalexin to cover staph and strep. The next day she was no better, again he walked her for clinic visit and erythema and induration were worse and fever persisted. Dr. arranged for her to be admitted an personally wheeled her to her room and arranged for STAT dose of Vancomycin. She remained febrile yesterday on vanc and UNASYN. I visited her twice. ID was consulted overnight. They advised that we report the lot number of the vaccine we gave the patient to the HD. Dr. spoke to the lady and she stated nothing unusual and observed the usual antiseptic procedure. The patient will go home today on Linezolid.
flu like symptoms; achy and had pain shooting through her muscles; achy; This spontaneous case was reported by a patient family member or friend and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (achy and had pain shooting through her muscles) and PAIN (achy) in a 67-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     Patient had no relevant medical history conditions, allergy, concomitant diseases and risk factor.     On 13-Oct-2023, the patient received third dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 15-Oct-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). In October 2023, the patient experienced PAIN (achy and had pain shooting through her muscles) and PAIN (achy). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (achy and had pain shooting through her muscles) and PAIN (achy) had not resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-746389 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-746389:Husband's case
Subsequently post vax, the pt experienced a dime size reaction at the injection site and erythema at injection site which has not yet resolved. The reaction is noted as painful with
Hand swelled up 3 times the size it was supposed to be, fingers and arm went numb
Left lateral thigh with 6" diameter erythemic, macular, swollen area and tender to touch. Treated with Atarax, Motrin and compresses.
Patient fainted within 15 minutes of vaccination.  Patient felt better after resting and drinking some juice; was released to home.
I had the regular know side affects after the vaccine, but I had shoulder and neck pain that limited my mobility. After the second dose my peripheral vision was off. I was also noticed I had foggy brain, stomach and digestive pain that lasted for about 2-3 weeks. I did not see a doctor.
Pt recvd measles vax on 22AUG91 & on 31AUG91 pt devel a h/a & a rash on upper body which persisted 1 day; no further details were provided;
In bed for 3 weeks sicker than a dog; In bed for 3 weeks sicker than a dog; General side effects; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (In bed for 3 weeks sicker than a dog), BEDRIDDEN (In bed for 3 weeks sicker than a dog) and ADVERSE DRUG REACTION (General side effects) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (In bed for 3 weeks sicker than a dog), BEDRIDDEN (In bed for 3 weeks sicker than a dog) and ADVERSE DRUG REACTION (General side effects). At the time of the report, ILLNESS (In bed for 3 weeks sicker than a dog), BEDRIDDEN (In bed for 3 weeks sicker than a dog) and ADVERSE DRUG REACTION (General side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
nausea, vomiting, dizziness, lightheadedness, headache, feeling of heart palpitations with associated shortness of breath IV ondansetron, IV bolus normal saline ED visit for > 5 hrs.
Body ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache) and HEADACHE (headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Body ache) and HEADACHE (headache). At the time of the report, MYALGIA (Body ache) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. No treatment information provided.
Vomiting; Fever persisting for 12 hours; Chills; Nausea; Arm pain; Muscle soreness; Tiredness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8735) via an unspecified route of administration in the right arm on 26Apr2021 at 12:00 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history included allergies to dogs, cats, dust mites and strawberries. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER7533) via an unspecified route of administration in the right arm on 05Apr2021 at 12:00 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. On 26Apr2021 at 23:00, the patient experienced fever which persisted for 12 hours, chills, nausea, arm pain, muscle soreness, tiredness and headache. On 27Apr2021 at 08:00, day after getting the shot, the patient experienced vomiting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measure for fever included treatment with TYLENOL. The patient did not receive any treatment for the chills, nausea, arm pain, muscle soreness, tiredness, headache and vomiting. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, nausea, arm pain, muscle soreness, tiredness, headache and vomiting were recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
ABOUT 5 DAYS AFTER TAKING THE VACCINE BOTH OF MY EYE LIDS APPEARED BRUISED AND PURPLE
PUNCTURED VIAL WAS IN THE FRIDGE FOR LONGER THAN THE 6 HOURS; DOSE FROM THIS VIAL WAS ADMINISTERED TO PATIENT; .This spontaneous report received from a pharmacist concerned a 58 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no allergy info on file. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 204A21A, expiry: 23-JUN-2021) dose was not reported, administered on 28-APR-2021 11:30 at left arm for prophylactic vaccination. No concomitant medications were reported. On 28-APR-2021, the subject experienced punctured vial was in the fridge for longer than the 6 hours. On 28-APR-2021, the subject experienced dose from this vial was administered to subject. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the punctured vial was in the fridge for longer than the 6 hours was not reported. This report was non-serious. This case, from the same reporter is linked to 20210502575 and 20210501669.
5 1/2 cm area of redness and warmth at (L) deltoid injection site, temp 99.2.
Information has been received from a health professional concerning a 56 year old female who on 04/11/2003 (also noted as Friday 04/09/2003) was vaccinated with a 0.5ml dose of pneumococcal vaccine 23 polyvalent.  On 04/13/2003 the patient did not have a fever.  The patient noted that she was last vaccinated with a dose of pneumococcal vaccine 23 polyvalent (manufacturer unknown) four and a half years ago and asked if she could have been vaccinated too soon.  The patient was referred to her primary medical doctor or to the local emergency room.  On 05/05/2003, it was reported by a RN that there was no other additional information which she had to offer.  On 05/09/2003 it was reported that the patient did not give her phone number or her physician's name.  No further information is expected.
Patient developed left sided jaw pain approximately one week following Td. It is described as an occasional dull ache which becomes painful when trying to open jaw. The patient hears and feels a "squishy" sensation when opening the jaw.
24 HOURS after vaccine was given, it was noticed that the patient's injection site was very red, irritated, swollen, hard and warm  to the touch, and appeared bruised.  The area was approximately 3 inches wide. Patient did not have any other concerns  other than local irritation. Patient was given motrin and cold compresses to the swollen /affected area.
Person reported Sjogren's syndrome symptoms starting after taking the vaccine.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (unknown if pregnant) received bnt162b2 (BNT162B2), on 03Feb2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, administration date=03Jan2022 (as reported), ), for Covid-19 immunization. The following information was reported: SJOGREN'S SYNDROME (medically significant), outcome "recovering", described as "Person reported Sjogren's syndrome symptoms starting after taking the vaccine.". The event "person reported sjogren's syndrome symptoms starting after taking the vaccine." required physician office visit. It was unknown if therapeutic measures were taken as a result of sjogren's syndrome.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
I experienced a cyst in my left armpit, I had to have it removed due to the pain. I've also had two miscarriages after being vaccinated, due to uterine polyps.
pt recvd vax &1 to 1 1/2 hrs p/inject exp numbness, pain up to the rt elbow, tingling & ice cold sensation in the ring & pinky fingers of the lt hand;
Within 3 minutes of receiving vaccine, patient started to feel lightheaded/dizzy. Within 5 to 7 minutes, standing was difficult and loss of consciousness seemed imminent. Moderate nausea was experienced, and patient also experienced what may be best described as a mild to moderate "hot flash". Patient sat down and bent over, which helped, then was escorted to a bed. Nausea passed within a few minutes of lying down and elevating feet, dizziness passed within 7 minutes. After 15 minutes, patient's head was "foggy" but other symptoms had abated. Blood pressure was still low. Patient left the premises by his own assessment of his well-being; his balance was a little off, but it was mostly just a nuisance. At no time did the patient observe hives, rash, tinnitus, constricted breathing, or elevated heart rate.
23 hours after receiving the shot, I had the chills, fever, body aches, headache for about 2 1/2 days. Two weeks later I had a virus that I was to just rest and stay hydrated. A month later, I have been told I have shingles.
she was injected, sh stopped eating and talking, the doctor watched her for 2 days. had her transported to the hospital. i was told she had tested positive for COVID 2 times once at the home and once at the hospital. with in 2 DAYS at the hospital  she wa on a ventilator 2 days later she died. i talked with the rehab center and confirmed she tested negative for COVID on Dec 27th 2020 and was given the Vaccine on the 29th Dec 202 was in the hospital 4 day later, was on a ventilator 4 days after that   then died a few day later as her heart stopped beating. all the while i had POA and was not contacted by Hospital staff until after they had made the next step.
The first 2 days I had a fever of 102 degrees. I was light headed and dehydrated and became extremely fatigued with body aches. Next day I went to the Dr and was diagnosed with COVID-19 and strep throat. 2 days after I experienced lost of smell and taste. Then chest tightness. Two days after I was on the road to recovery. I had taken Motrin and my inhaler.
Information has been received from a registered nurse (RN) concerning a 28-year-old female who on 23-AUG-2005 was vaccinated subcutaneously with a first dose of varicella virus vaccine live (Oka/Merck) (lot# 649439/0115R) adult schedule. About one day after being vaccinated, on 24-AUG-2005,5 the patient experienced vesicular rash. Unspecified medical attention was sought. The rash has resolved but the patient still complains of soreness and redness at the injection site. At the time of reporting it was reported that the patient is recovering from the soreness and redness at the injection site. Additional information has been requested.
pt recv vax & a few hr later reported dizziness & fatigue;these sx cont for 48hr & were accompanied by nausea, vomiting & an inj site rxn characterized by tenderness & redness;pt recovered
HARD TIME BREATHING; COLD; CHILLS; FEVER; PAIN AT INJECTION SITE; This spontaneous report received from a parent concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 14-MAR-2021 10:15 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 14-MAR-2021, the subject experienced cold. On 14-MAR-2021, the subject experienced chills. On 14-MAR-2021, the subject experienced fever. On 14-MAR-2021, the subject experienced pain at injection site. Laboratory data included: Body temperature (NR: not provided) 101 F. On an unspecified date, the subject experienced hard time breathing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, chills, cold, pain at injection site, and hard time breathing. This report was non-serious.
Information has been received from a nurse concerning a 78 year old female with high cholesterol, gastrooesophageal reflux disease and degenerative joint and a history of renal artery stent placement who on 03-MAR-2008 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot #658673/0990U). Concomitant therapy included atorvastatin calcium (LIPITOR), esomeprazole magnesium (NEXIUM) and alendroanate sodium (MSD). On 06-MAR-2008 (a couple of days later), the patient experienced syncope. The patient was taken to the Emergency Room but it was unknown if the patient was admitted. Subsequently on an unspecified date, the patient recovered from syncope. The discharge papers stated that syncope was related to therapy with pneumococcal 23v polysaccharide vaccine. No product quality complaint was involved. Additional information has been requested.
The pt developed swelling, redness, warmth, pain and itching on 10/24/01 that lasted about 4 days. The redness was about 4" in size. She was treated with Benadryl and Cortisone cream.
pt recvd 2 doses of Engerix-B 13 & 14SEP91 & was treated w/Terramycin & Celestone for sinusitis; recvd 3rd dose of Engerix-B 17ARP92 titer result was low; recvd a booster dose; second booster is being considered prior to retesting;
I became super fatigue, hip pain, stiff neck, on June 22 I couldn't get out of bed. On the 25th of June I was diagnosed with polymyalgia rheumatica.
Per mother of the pt - pt given flu shot and feeling ok afterwards. They started walking out of the pharmacy / store, pt and sister was talking about needles & blood when she began to feel queasy because of the talk (pt has history of fainting when.
Patient developed redness and swelling at injection site that spread all over upper arm. Pt visited MD, was given KEFLEX due to infection.
Became unresponsive with contracture of hands and arms, aching back. Unresponsive for approx. 1 minute and then responded to verbal stimuli. Relaxed muscles for 1-2 minutes at which time another similar episode occurred. Sent to her PMD for exam.
My symptoms started around 9:00am the following morning. It started with an extreme headache, it felt like a vice on my head. I also had loud ringing in my ears. I experienced Nausea and weakness. My face and chest went numb. I had extreme body chills, and shook for the majority of Friday. On Saturday I sweated uncontrollably, and was sweating through my clothing. The injection site swelled and raised about and inch of my skin and was very red. The red area started the size of a baseball and has progressively grown in diameter over the course of the last four days.
This spontaneous report was received from a medical assistant via a company representative, referring to a female patient of unknown age. There was no information reported regarding the patient's medical history, concomitant medication, concurrent conditions and drug reactions/allergies. In December 2018 (reported as: "2 months ago"), the patient received her first dose of GARDASIL 9 route reported as: "on the deltoid of the arm") (strength, lot number and expiration date not provided) to avoid HPV (prophylaxis). In December 2018 (reported as: "The same day as vaccination"), the patient got an unspecified rash and her arm was swollen for two days. It was reported that the events "went away" without treatment and that she did not seek medical attention. No lab diagnostics/studies were performed. At the time of reporting the patient had recovered from the events, on an unknown date. The clinician declined to administer the second dose of GARDASIL 9. There was no causality assessment provided between the events and GARDASIL 9.
Patient developed substernal chest pressure and lightheadedness prompting visit to the ER where he was found to have a STEMI and developed Vfib arrest and had cardioversion x 2. Patient was found to have an inferior wall MI.   Mechanical thrombectomy was performed for a thrombotic occlusion of the mid-distal RCA and DES X 1 placed. Significant CAD was present in the proximal-mid LAD and proximal-mid left circumflex.
Painful area on right shoulder where vaccine was administered. It would flare up from time to time. Come and go. This went on for some time; perhaps 6 months or so. As of today, 6/13/2017, this same area is still tender. In 2016 I started developing swelling and painful joints. Shoulders, elbows, wrists, ankles, hips. It is like I am having some sort of autoimmune response from the vaccine.
Patient was administered second dose of Moderna on day 23 post the first dose, instead of on day 28. Patient tolerated the vaccine well and stayed the full 15 minutes after administration. No visible adverse event occurred.
I had runny nose, cough and very mild cold and I called my doctor and got the antiviral medication and it was gone after a couple of days. The cough and congestion persistent for a while in Nov 22. Tested positive on 28Nov22. In Dec22, I was losing 5 to 10 pounds and trouble breathing . After many tests I was diagnosed with Overactive Typhroid  late Feb2023. I was in the ER because of thyroid on 24MAR2023 for 3 hours.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 21-JUL-2016 the patient was vaccinated with an improperly stored dose of GARDASIL 9 (0.5ml, lot # L044475, expiration date 12-MAY-2017, route unknown). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 144 hours with the highest recorded temperature of 12 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report was received from a nurse, referring to a 25 year old female patient. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported. On 24-JAN-2019, the 25 year old patient was vaccinated with ZOSTAVAX strength reported as 19400 PFU, subcutaneously, lot# R023356 and expiration date 28-JUN-2019, for prophylaxis (strength, dose and frequency were not reported). No adverse effect reported.